Daniela Francisci (D Francisci)

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Topics

Pseudomonas Aeruginosa

Coronavirus Disease

Intensive Care Unit

Top Venues

Case reports in infectious diseases

European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Anna Gidari, Carlo Pallotto, Daniela Francisci
Daptomycin eosinophilic pneumonia, a systematic review of the literature and case series. Infection (2024)
Lia Fiaschi, Filippo Dragoni, Elisabetta Schiaroli, Annalisa Bergna, Barbara Rossetti, Federica Giammarino, Camilla Biba, Anna Gidari, Alessia Lai, Cesira Nencioni, Daniela Francisci, Maurizio Zazzi, Ilaria Vicenti
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2. Viruses 14 (7) (2022)
Giuseppe Vittorio De Socio, Anna Gidari, Francesco Sicari, Michele Palumbo, Daniela Francisci
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study. Infection 49 (5) (2021)
Anna Gidari, Marco Nofri, Luca Saccarelli, Sabrina Bastianelli, Samuele Sabbatini, Silvia Bozza, Barbara Camilloni, Igino Fusco-Moffa, Claudia Monari, Michael P Casaer, Antonella Mencacci, Daniela Francisci
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 40 (1) (2020)
Anna Gidari, Giuseppe Vittorio De Socio, Samuele Sabbatini, Daniela Francisci
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection. Infectious diseases (London, England) 52 (10) (2020)
L M Saraca, C Di Giuli, F Sicari, G Priante, F Lavagna, Daniela Francisci
Use of Ceftolozane-Tazobactam in Patient with Severe Medium Chronic Purulent Otitis by XDR Pseudomonas aeruginosa. Case reports in infectious diseases 2019 (2019)